Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Seizure Therapy With Intravenous Levetiracetam and Lorazepam.

Trial Profile

Seizure Therapy With Intravenous Levetiracetam and Lorazepam.

Withdrawn prior to enrolment
Phase of Trial: Phase II/III

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Levetiracetam; Lorazepam
  • Indications Seizures
  • Focus Therapeutic Use
  • Acronyms STILL
  • Most Recent Events

    • 18 Apr 2012 Actual end date changed from Dec 2010 to May 2010 as reported by ClinicalTrials.gov.
    • 19 Jul 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 27 May 2008 Patient numbers amended from 350 to 100 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top